Neuroprotective Agents Market: Introduction

Neuroprotection or prevention of neuronal loss is a complicated molecular process that is mediated by various cellular pathways. The most common conditions associated with nervous system involvement and intensive care unit (ICU) admission are trauma, shock, stroke, sepsis, traumatic brain injury (TBI), and ruptured brain aneurysm. Beneficial use of many agents has been reported in the prevention of neuronal cell death in animal models but supportive data from clinical trials is still lacking. Approximately 40% of energy produced is consumed in the maintenance of neuronal & glial integrity & the remainder is used for electrophysiologic activity. Neuroprotection refers to the use of therapies that reduce brain injury during acute stroke, through actions on the brain rather than by improving blood flow. Several neuroprotective agents have been tested under high quality of transition of preclinical results to clinical trial. For example, the first multicenter trial of experimental stroke research has been conducted to evaluate the effect of anti-CD49 d antibodies which inhibit the migration of leukocytes into the brain and reduce the infarct volume after a small cortical stroke.

Are you a Start-up willing to make it big in the Business? Grab an Exclusive PDF Brochure of Neuroprotective Agents Market Report

Key Drivers of Global Neuroprotective Agents Market

  • Increase in Incidence and Prevalence of Neurodegenerative Diseases

    Neurological disorders are an important cause of disability and death worldwide. The major neurodegenerative diseases, i.e., ‘the big three’, Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), account for considerable morbidity and mortality in the U.S. elderly population.

  • Increase in Stroke and Traumatic Central Nervous System Injuries

    Traumatic brain injuries and stroke cause secondary biochemical changes in brain. This results into tissue damage and associated neuronal cell death. Neuroprotective treatments limit secondary tissue loss and improve behavioral outcome in patients. This outcome is studied in several clinical trials.

North America to Hold Major Share of Global Neuroprotective Agents Market

North America is expected to hold major share of the global neuroprotective agents market during the forecast period. According to the Parkinson’s Foundation, 60,000 people in the U.S. are diagnosed of Parkinson’s each year. Hence, North America is the major market for these products. Worldwide, an estimated five to seven million people are living with Parkinson’s disease, which would increase the demand for neuroprotective drugs and spur research & development. The neuroprotective agents market in Asia Pacific is projected to expand at a rapid pace during the forecast period. This can be attributed to growing trend of preventive health care measures in North America.

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Neuroprotective Agents Market Report

Key Players Operating in Global Market

The global neuroprotective agents market is highly concentrated, due to strong presence of a few key players. Several manufacturers hold major share in the market in their respective regions. Leading players operating in the global neuroprotective agents market are:

  • Bayer Healthcare, Eisai Inc.
  • GlaxoSmithKline Plc
  • Merck
  • Serono S.A.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Genervon Biopharmaceuticals
  • NeuroVive Pharmaceutical
  • Ceregene, BHRPharma LLC
  • Neuren Pharmaceuticals
  • Allon therapeutics, Inc.
  • Bionure Inc.

Global Neuroprotective Agents Market: Research Scope

Global Neuroprotective Agents Market, by Drug

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Anti-inflammatory & Anti-apoptotic Agents
  • Neurotropic Factors
  • Mitochondrial Dysfunction Regulators
  • Metal Ion Chelators
  • Ion Channel Modulators
  • Free Radical Trappers
  • Anti-excitotoxic Agents
  • Others

Global Neuroprotective Agents Market, by Indication

  • Alzheimer's Disease
  • Multiple Sclerosis
  • Parkinson's Disease
  • Ocular Degeneration (retinal disorders)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Huntington's Disease
  • Neuropathies
  • Brain Injury
  • Other Disorders

Global Neuroprotective Agents Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Neuroprotective Agents Market

Pre Book